Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Tango Therapeutics, Inc. (TNGX) had Operating Margin of -178.39% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$62.38M |
|
$-101.59M |
|
-- |
|
$62.38M |
|
$173.67M |
|
$-111.29M |
|
$9.70M |
|
$-101.59M |
|
$-101.59M |
|
$-101.59M |
|
$-101.59M |
|
$-101.59M |
|
$-101.59M |
|
$-111.29M |
|
$-111.70M |
|
116.17M |
|
116.17M |
|
$-0.87 |
|
$-0.87 |
|
| Balance Sheet Financials | |
$353.76M |
|
$6.87M |
|
$44.93M |
|
$398.69M |
|
$21.68M |
|
-- |
|
$30.83M |
|
$52.51M |
|
$346.18M |
|
$346.18M |
|
$346.18M |
|
135.94M |
|
| Cash Flow Statement Financials | |
$-138.89M |
|
$-40.87M |
|
$222.50M |
|
$72.10M |
|
$114.85M |
|
$42.75M |
|
$26.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
|
Operating Margin |
-178.39% |
-178.39% |
|
-179.05% |
|
-162.85% |
|
-162.85% |
|
$-139.93M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-29.35% |
|
-29.35% |
|
-25.48% |
|
-29.35% |
|
$2.55 |
|
$-1.20 |
|
$-1.20 |
|